Importantly, complete clinical phenotypes and biological correlates, such as those obtained through specific ALPS-related studies (ALPS Immune-panel, cytokines, Vitamin B12, and Fas-mediated apoptosis) would be helpful to provide supporting evidence for variant classification and should be considered in the variant classification work up. The gene discussed is FAS; the disease is autoimmune lymphoproliferative syndrome.